2,6,10,14,18,22-Tetracosahexaene,2,6,10,15,19,23-hexamethyl-, (2E,6E,10E,14E,18E)- cas no:111-02-4
Synonyms: 2,6,10,14,18,22-Tetracosahexaene,2,6,10,15,19,23-hexamethyl-, (all-E)- (8CI); (E,E,E,E)-Squalene;2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; Nikko Squalane EX;Spinacen; Spinacene; Squalen; Squalene; Super Squalene; all-trans-Squalene;trans-Squalene
Name2,6,10,14,18,22-Tetracosahexaene,2,6,10,15,19,23-hexamethyl-, (2E,6E,10E,14E,18E)-
CAS111-02-4
Synonyms2,6,10,14,18,22-Tetracosahexaene,2,6,10,15,19,23-hexamethyl-, (all-E)- (8CI); (E,E,E,E)-Squalene;2,6,10,15,19,23-Hexamethyl-2,6,10,14,18,22-tetracosahexaene; Nikko Squalane EX;Spinacen; Spinacene; Squalen; Squalene; Super Squalene; all-trans-Squalene;trans-Squalene
EINECS(EC#)203-826-1
Molecular FormulaC30H50
Molecular Weight410.72
AppearanceClear, slightly yellow liquid with a faint odor.
refractive index1.4945-1.4965
storage temp2-8°C
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass4.1
Safety
Safety Statements 24/25
24/25: Trans-squalene (111-02-4) used, avoid contact with skin and eyes
WGK Germany 2
RTECS XB6010000
F 8-10-23
HS Code 29012980
HS Code 29012980
Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
mouse |
LD50 |
intravenous |
1800mg/kg (1800mg/kg) |
|
Japanese Journal of Cancer Research. Vol. 76, Pg. 1021, 1985. |
mouse |
LD50 |
oral |
5gm/kg (5000mg/kg) |
|
Japanese Journal of Cancer Research. Vol. 76, Pg. 1021, 1985. |